Biotech

All Articles

Gilead pays for J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its own liver illness medicine selad...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may observe the business putting together camping tents at base...

Entero giving up personnel, moving out of office as well as pausing R&ampD

.Mattress Liquidators has transformed Entero Rehabs white as a sheet. The lender got Entero to settl...

Exelixis drops ADC after deciding it is actually no suit for Tivdak

.Exelixis is actually quiting on its cells aspect (TF)- targeting antibody-drug conjugate after conc...

Relay dislikes SHP2 inhibitor after Genentech leaves

.3 weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay Therapeutics...

Stoke's Dravet syndrome med discharged of partial clinical grip

.Stoke Therapies' Dravet syndrome medicine has actually been devoid of a partial hold, getting rid o...

Fierce Biotech's Gabrielle Masson presents Fierce 15 at NYSE

.Intense Biotech Partner Editor Gabrielle Masson offered the 2024 lesson of Tough 15 champions on th...

Daiichi spends Merck $170M to develop lung cancer T-cell engager treaty

.Merck &amp Co. has actually rapidly redeemed a number of the expenses of its own Javelin Rehabs buy...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin administered a spring tidy of its pipeline in April, the company has decided that it...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks deal

.Huge Pharmas stay stuck to the suggestion of molecular adhesive degraders. The latest company to ob...